The role of optical coherence tomography in anti-vascular endothelial growth factor therapies

Anne Fung, Nikolas London, Philip Rosenfeld

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Vascular endothelial growth factor (VEGF) has emerged as a key mediator of angiogenesis and macular edema in ocular diseases such as neovascular macular degeneration, vein occlusions, and diabetic retinopathy.1,2 Therapies to neutralize VEGFs action in ocular diseases have been used to successfully combat VEGFs pathogenic role in the eye.

Original languageEnglish (US)
Title of host publicationRetinal Angiography and Optical Coherence Tomography
PublisherSpringer New York
Pages279-288
Number of pages10
ISBN (Print)9780387689869
DOIs
StatePublished - Dec 1 2009

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The role of optical coherence tomography in anti-vascular endothelial growth factor therapies'. Together they form a unique fingerprint.

  • Cite this

    Fung, A., London, N., & Rosenfeld, P. (2009). The role of optical coherence tomography in anti-vascular endothelial growth factor therapies. In Retinal Angiography and Optical Coherence Tomography (pp. 279-288). Springer New York. https://doi.org/10.1007/978-0-387-68987-6_15